600420.SS
600420.SS
CNE000001JG2
SHANGHAI SHYNDEC PHARMACEUTICAL
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 9.363.074.210 10.937.525.114
14.4%
Cost of Revenue 6.327.073.047 6.645.214.333
4.8%
Gross Profit 3.036.001.163 4.292.310.782
29.3%
1.753.158.209 2.495.720.246
29.8%
Operating Income 1.282.842.953 1.796.590.536
28.6%
Pretax Income 1.327.585.038 1.673.053.837
20.6%
Net Income Common Stockholders 941.601.686 1.083.622.882
13.1%
-- --
--
-- --
--
ende